ID

39267

Descrizione

Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Japanese Patients With Essential Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT01599104

collegamento

https://clinicaltrials.gov/show/NCT01599104

Keywords

versioni (1)
  1. 14/12/19 14/12/19 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

14 dicembre 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Essential Hypertension NCT01599104

Inglese

Eligibility Essential Hypertension NCT01599104

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with mild-to-moderate hypertension, untreated or currently taking antihypertensive therapy.
Descrizione

Mild hypertension untreated | Moderate hypertension untreated | Hypertension, mild | Hypertension, moderate | Antihypertensive therapy

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3276943
UMLS CUI [1,2]
C0332155
UMLS CUI [2,1]
C1969581
UMLS CUI [2,2]
C0332155
UMLS CUI [3]
C3276943
UMLS CUI [4]
C1969581
UMLS CUI [5]
C0585941
treated patients (using antihypertensive treatments within 4 weeks prior to visit 1) must have an mssbp ≥ 150 mmhg and < 180 mmhg at the randomization visit (visit 201) and mssbp ≥140 mmhg < 180 mmhg at the visit immediately proceeding visit 201 (visit 102 or 103).
Descrizione

Patients Treated | Antihypertensive therapy | Sitting systolic blood pressure mean | Randomization Visit | Visit preceding

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1522326
UMLS CUI [2]
C0585941
UMLS CUI [3,1]
C1319893
UMLS CUI [3,2]
C0444504
UMLS CUI [4,1]
C0034656
UMLS CUI [4,2]
C0008952
UMLS CUI [5,1]
C0008952
UMLS CUI [5,2]
C0332152
untreated patients (newly diagnosed with essential hypertension or having a history of hypertension but have not been taking any antihypertensive drugs for at least 4 weeks prior to visit 1) must have an mssbp ≥ 150 mmhg and < 180 mmhg at both visit 1 and visit 201.
Descrizione

Patients untreated | Essential Hypertension Newly Diagnosed | History of hypertension | Sitting systolic blood pressure mean

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0332155
UMLS CUI [2,1]
C0085580
UMLS CUI [2,2]
C1518321
UMLS CUI [3]
C0455527
UMLS CUI [4,1]
C1319893
UMLS CUI [4,2]
C0444504
patients must have an absolute difference of ≤15 mmhg in mssbp between visit 201 and the immediately preceding visit;
Descrizione

Difference Sitting systolic blood pressure mean | Randomization Visit | Visit preceding

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1705242
UMLS CUI [1,2]
C1319893
UMLS CUI [1,3]
C0444504
UMLS CUI [2,1]
C0034656
UMLS CUI [2,2]
C0008952
UMLS CUI [3,1]
C0008952
UMLS CUI [3,2]
C0332152
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
severe hypertension (msdbp ≥110 mmhg and/or mssbp ≥ 180 mmhg).
Descrizione

Hypertension, severe | Sitting diastolic blood pressure mean | Sitting systolic blood pressure mean

Tipo di dati

boolean

Alias
UMLS CUI [1]
C4013784
UMLS CUI [2,1]
C1319894
UMLS CUI [2,2]
C0444504
UMLS CUI [3,1]
C1319893
UMLS CUI [3,2]
C0444504
history of angioedema, drug-related or otherwise, as reported by the patient.
Descrizione

Angioedema Drug-induced | Angioedema

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0002994
UMLS CUI [1,2]
C0458082
UMLS CUI [2]
C0002994
history or evidence of a secondary form of hypertension, including but not limited to any of the following: renal parenchymal hypertension, renovascular hypertension (unilateral or bilateral renal artery stenosis), coarctation of the aorta, primary hyperaldosteronism, cushing's disease, pheochromocytoma, polycystic kidney disease, and drug-induced hypertension.
Descrizione

Secondary hypertension | Parenchymal renal hypertension | Hypertension, Renovascular | Unilateral renal artery stenosis | Bilateral renal artery stenosis | Aortic coarctation | Conn Syndrome | Cushing's disease | Pheochromocytoma | Polycystic Kidney Diseases | Hypertensive disease Drug-induced

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0155616
UMLS CUI [2]
C0264649
UMLS CUI [3]
C0020545
UMLS CUI [4]
C0856759
UMLS CUI [5]
C0856760
UMLS CUI [6]
C0003492
UMLS CUI [7]
C1384514
UMLS CUI [8]
C0221406
UMLS CUI [9]
C0031511
UMLS CUI [10]
C0022680
UMLS CUI [11,1]
C0020538
UMLS CUI [11,2]
C0458082
patients who previously entered a lcz696 study and had been randomized or enrolled into the active drug treatment epoch.
Descrizione

Study Subject Participation Status | LCZ 696 Clinical Trial

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C2933615
UMLS CUI [2,2]
C0008976
other protocol-defined inclusion/exclusion criteria may apply.
Descrizione

Eligibility Criteria Study Protocol

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Ritorna all'inizio della pagina

Similar models

Eligibility Essential Hypertension NCT01599104

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Mild hypertension untreated | Moderate hypertension untreated | Hypertension, mild | Hypertension, moderate | Antihypertensive therapy
Item
patients with mild-to-moderate hypertension, untreated or currently taking antihypertensive therapy.
boolean
C3276943 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C1969581 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
C3276943 (UMLS CUI [3])
C1969581 (UMLS CUI [4])
C0585941 (UMLS CUI [5])
Patients Treated | Antihypertensive therapy | Sitting systolic blood pressure mean | Randomization Visit | Visit preceding
Item
treated patients (using antihypertensive treatments within 4 weeks prior to visit 1) must have an mssbp ≥ 150 mmhg and < 180 mmhg at the randomization visit (visit 201) and mssbp ≥140 mmhg < 180 mmhg at the visit immediately proceeding visit 201 (visit 102 or 103).
boolean
C0030705 (UMLS CUI [1,1])
C1522326 (UMLS CUI [1,2])
C0585941 (UMLS CUI [2])
C1319893 (UMLS CUI [3,1])
C0444504 (UMLS CUI [3,2])
C0034656 (UMLS CUI [4,1])
C0008952 (UMLS CUI [4,2])
C0008952 (UMLS CUI [5,1])
C0332152 (UMLS CUI [5,2])
Patients untreated | Essential Hypertension Newly Diagnosed | History of hypertension | Sitting systolic blood pressure mean
Item
untreated patients (newly diagnosed with essential hypertension or having a history of hypertension but have not been taking any antihypertensive drugs for at least 4 weeks prior to visit 1) must have an mssbp ≥ 150 mmhg and < 180 mmhg at both visit 1 and visit 201.
boolean
C0030705 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C0085580 (UMLS CUI [2,1])
C1518321 (UMLS CUI [2,2])
C0455527 (UMLS CUI [3])
C1319893 (UMLS CUI [4,1])
C0444504 (UMLS CUI [4,2])
Difference Sitting systolic blood pressure mean | Randomization Visit | Visit preceding
Item
patients must have an absolute difference of ≤15 mmhg in mssbp between visit 201 and the immediately preceding visit;
boolean
C1705242 (UMLS CUI [1,1])
C1319893 (UMLS CUI [1,2])
C0444504 (UMLS CUI [1,3])
C0034656 (UMLS CUI [2,1])
C0008952 (UMLS CUI [2,2])
C0008952 (UMLS CUI [3,1])
C0332152 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Hypertension, severe | Sitting diastolic blood pressure mean | Sitting systolic blood pressure mean
Item
severe hypertension (msdbp ≥110 mmhg and/or mssbp ≥ 180 mmhg).
boolean
C4013784 (UMLS CUI [1])
C1319894 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C1319893 (UMLS CUI [3,1])
C0444504 (UMLS CUI [3,2])
Angioedema Drug-induced | Angioedema
Item
history of angioedema, drug-related or otherwise, as reported by the patient.
boolean
C0002994 (UMLS CUI [1,1])
C0458082 (UMLS CUI [1,2])
C0002994 (UMLS CUI [2])
Secondary hypertension | Parenchymal renal hypertension | Hypertension, Renovascular | Unilateral renal artery stenosis | Bilateral renal artery stenosis | Aortic coarctation | Conn Syndrome | Cushing's disease | Pheochromocytoma | Polycystic Kidney Diseases | Hypertensive disease Drug-induced
Item
history or evidence of a secondary form of hypertension, including but not limited to any of the following: renal parenchymal hypertension, renovascular hypertension (unilateral or bilateral renal artery stenosis), coarctation of the aorta, primary hyperaldosteronism, cushing's disease, pheochromocytoma, polycystic kidney disease, and drug-induced hypertension.
boolean
C0155616 (UMLS CUI [1])
C0264649 (UMLS CUI [2])
C0020545 (UMLS CUI [3])
C0856759 (UMLS CUI [4])
C0856760 (UMLS CUI [5])
C0003492 (UMLS CUI [6])
C1384514 (UMLS CUI [7])
C0221406 (UMLS CUI [8])
C0031511 (UMLS CUI [9])
C0022680 (UMLS CUI [10])
C0020538 (UMLS CUI [11,1])
C0458082 (UMLS CUI [11,2])
Study Subject Participation Status | LCZ 696 Clinical Trial
Item
patients who previously entered a lcz696 study and had been randomized or enrolled into the active drug treatment epoch.
boolean
C2348568 (UMLS CUI [1])
C2933615 (UMLS CUI [2,1])
C0008976 (UMLS CUI [2,2])
Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply.
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial